^
    Apply
    Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma (NCI-2018-00872) (NCT03452930)
    Phase 1
    M.D. Anderson Cancer Center
    Active, not recruiting
    Last update posted :
    05/15/2024
    Initiation :
    08/13/2018
    Primary completion :
    12/30/2024
    Completion :
    12/30/2024
    MGMT
    |
    IDH wild-type
    |
    tinostamustine (EDO-S101)
    Study of Tinostamustine for Adjuvant Treatment of Glioblastoma (NCT05432375)
    Phase 1
    Mundipharma Research Limited
    Active, not recruiting
    Last update posted :
    01/23/2024
    Initiation :
    07/01/2022
    Primary completion :
    07/01/2024
    Completion :
    11/30/2024
    MGMT
    |
    IDH wild-type
    |
    temozolomide • tinostamustine (EDO-S101)
    A Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCL (NCT04279938)
    Phase 1
    Royal Marsden NHS Foundation Trust
    Withdrawn
    Last update posted :
    02/21/2020
    Initiation :
    09/01/2018
    Primary completion :
    03/01/2020
    Completion :
    01/01/2021
    CD20
    |
    Keytruda (pembrolizumab) • Rituxan (rituximab) • tinostamustine (EDO-S101)